Tear tumor necrosis factor-alpha levels in patients with Parkinson’s disease: The effect of deep brain stimulation
Objective: To evaluate tear tumor necrosis factor-alpha (TNF-α) levels in samples of two Parkinson’s disease (PD) patients treated with subthalamic nucleus (STN) deep brain stimulation…Feedback Controlled DBS in Parkinson’s Disease using Electrocorticography
Objective: To provide a proof of principle implementation of closed loop DBS in an office setting using narrowband γ and β power as modulatory signals…Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease
Objective: To report on a patient with Parkinsons’ disease (PD) who developed pathologic crying (PC) following chronic deep brain stimulation (DBS) of the subthalamic nucleus…Dynamic of symptoms of dopamine dysregulation syndrome after deep brain stimulation in patients with Parkinson`s disease
Objective: Assessment of the dynamics of dopamine dysregulation syndrome in patients with Parkinson`s disease after deep brain stimulation of the subthalamic nucleus compared with the…Excellent Non-motor Responses after Bilateral Subthalamic Deep Brain Stimulation in Parkinson’s Disease Patient with SNCA Duplication
Objective: We report a case of Parkinson's disease patient with SNCA duplication, who showed excellent response in both motor and non-motor symptoms after bilateral subthalamic stimulation. Background:…Asymptomatic and transitory postoperative hypodense lesion around deep brain stimulation electrode
Objective: To report the case of a patient that developed a post-operative asymptomatic, transitory, non-infection hypodense lesion around DBS lead, literature review and discussion of…Transcranial sonography in the prognosis of drug-induced parkinsonism
Objective: We investigated the substantia nigra (SN) echogenicity in drug-induced parkinsonism (DIP), Parkinson's disease (PD), and healthy controls. A subgroup analysis of DIP by clinical…Effects of the administration of levodopa on postural control under visual tasks
Objective: We tested if the administration of levodopa leads the patients with Parkinson’s disease to sway significantly more than the controls, especially under challenging visual…Effect of Deutetrabenazine on QTcF Interval in the AIM-TD Study: a 12-Week, Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Objective: To evaluate the effect of deutetrabenazine (DTB) on QT interval prolongation in patients with tardive dyskinesia (TD) in the AIM-TD study. Background: TD is…Off-Target Implications of Nurr1 Agonist Therapy in Parkinson’s disease
Objective: To examine the impact of Nurr1 agonists on regulation of striatal Nurr1 and levodopa (LD)-induced dyskinesias (LIDs) in a rat model of Parkinson’s disease…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.